Literature DB >> 16574653

CUTL1 is phosphorylated by protein kinase A, modulating its effects on cell proliferation and motility.

Patrick Michl1, Beate Knobel, Julian Downward.   

Abstract

CUTL1, also known as CDP (CCAAT Displacement Protein), Cut, or Cux-1, is a homeodomain transcription factor known to play an essential role in development and cell cycle progression. Previously, we identified CUTL1 as modulator of cell motility and invasiveness. Here we report that protein kinase A (PKA), known to inhibit tumor progression in various tumor types, directly phosphorylates CUTL1 at serine 1215 in NIH3T3 fibroblasts. The PKA-induced phosphorylation results in decreased DNA binding affinity of CUTL1 and diminished CUTL1-mediated cell cycle progression and cell motility. Furthermore, the expression of several CUTL1 target genes involved in proliferation and migration, such as DNA polymerase A and DKK2, was modulated by PKA-induced phosphorylation. These data identify CUTL1 as a novel target of PKA through which this protein kinase can modulate tumor cell motility and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574653     DOI: 10.1074/jbc.M600908200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Characterization of amyloid-β precursor protein intracellular domain-associated transcriptional complexes in SH-SY5Y neurocytes.

Authors:  Wulin Yang; Amy Yong Chen Lau; Shuizhong Luo; Qian Zhu; Li Lu
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

2.  Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle.

Authors:  Laurent Sansregret; David Gallo; Marianne Santaguida; Lam Leduy; Ryoko Harada; Alain Nepveu
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

3.  Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.

Authors:  Stefanie Ripka; Jan Riedel; Albrecht Neesse; Heidi Griesmann; Malte Buchholz; Volker Ellenrieder; Franz Moeller; Peter Barth; Thomas M Gress; Patrick Michl
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

4.  MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.

Authors:  Kentaro Kojima; Akemi Takata; Charles Vadnais; Motoyuki Otsuka; Takeshi Yoshikawa; Masao Akanuma; Yuji Kondo; Young Jun Kang; Takahiro Kishikawa; Naoya Kato; Zhifang Xie; Weiping J Zhang; Haruhiko Yoshida; Masao Omata; Alain Nepveu; Kazuhiko Koike
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

5.  Transcription factor CUTL1 is a negative regulator of drug resistance in gastric cancer.

Authors:  Tingting Li; Honghong Wang; Yimin Sun; Lina Zhao; Yi Gang; Xuegang Guo; Rei Huang; Zhiping Yang; Yanglin Pan; Kaichun Wu; Li Xu; Zhiguo Liu; Daiming Fan
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

6.  Anaplasma phagocytophilum increases cathepsin L activity, thereby globally influencing neutrophil function.

Authors:  Venetta Thomas; Swapna Samanta; Erol Fikrig
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

7.  p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin.

Authors:  Valerie Kedinger; Laurent Sansregret; Ryoko Harada; Charles Vadnais; Chantal Cadieux; Kelly Fathers; Morag Park; Alain Nepveu
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

8.  Effects of prenatal tobacco exposure on gene expression profiling in umbilical cord tissue.

Authors:  Naveed Hussain; Winfried Krueger; Jonathan Covault; Stephen Walsh; Henry R Kranzler; Cheryl Oncken
Journal:  Pediatr Res       Date:  2008-08       Impact factor: 3.756

Review 9.  Regulation of cell proliferation and differentiation in the kidney.

Authors:  Neal I Alcalay; Gregory B Vanden Heuvel
Journal:  Front Biosci (Landmark Ed)       Date:  2009-06-01

10.  CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation.

Authors:  Heidi Griesmann; Sebastian Mühl; Jan Riedel; Katharina Theuerkorn; Bence Sipos; Irene Esposito; Gregory B Vanden Heuvel; Patrick Michl
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.